Home | Welcome to Contract Pharma   
Last Updated Monday, December 22 2014

Print RSS Feed

Breaking News

December 19, 2014
Will focus on treatment of hematological malignancies and solid tumors   Read More »
December 19, 2014
BioChaperone Lispro could provide a new treatment option for diabetes  Read More »
December 19, 2014
ONO-4059 shows clinical activity in CLL and NHL  Read More »
December 18, 2014
Invests in a Thermo Fisher 16 twin screw extruder  Read More »
December 18, 2014
Aims to identify cellular responses for oncology immunotherapies  Read More »
December 18, 2014
To develop and commercialize highly potent analog CMX157  Read More »
December 18, 2014
Gains Phase I oncology candidate  Read More »
December 17, 2014
Site compliant with GMP but Form 483 notes three inspectional observations  Read More »
December 17, 2014
Amunix will receive an option fee and is eligible for additional milestones  Read More »
December 17, 2014
Includes a series of small molecule compounds against a cardiovascular drug target  Read More »
December 17, 2014
To develop and commercialize Janssen products with ENHANZE technology  Read More »
December 16, 2014
To focus on commercial manufacturing for solid dosage products  Read More »
December 16, 2014
Richards to support increased demand for manufacturing services  Read More »
December 16, 2014
To employ ERT’s patient safety and efficacy endpoint data collection solutions  Read More »
December 16, 2014
License agreement includes foam vehicle for Azelaic Acid   Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On